Compare eBay Inc (EBAY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Twist Bioscience Corp — how do they compare? eBay Inc trades at $111.54 (market cap $50.07B), while Twist Bioscience Corp trades at $90.08 (market cap $5.76B). The key difference: eBay Inc is far larger — about 8.7× Twist Bioscience Corp's market cap, and eBay Inc pays a 1.1% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| EBAY | TWST | |
|---|---|---|
Market Cap | $50.07B | $5.76B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $102.88 |
52-Week Low | $76.79 | $24.16 |
Enterprise Value | $53.41B | $5.69B |
Dividend Yield | 1.1% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $111.48, down 0.94% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported revenue of $11.10B in 2025 with a net income margin of 17.61%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights eBay's cleared acquisition of Depop and ongoing takeover interest from GameStop.
EBAY presents a mixed outlook with strong profitability and consistent earnings beats offset by high valuation multiples and competitive pressures. The stock's upside potential hinges on successful integration of acquisitions and advertising growth, while risks include market volatility and execution challenges in a dynamic e-commerce landscape.
Twist Bioscience (TWST) trades at $92.61, up 2.5% on the day, with a bullish technical signal and strong analyst support. The company shows improving revenue growth ($377M in 2025, up 20% year-over-year) but continues to report significant losses (-$77.7M net income). Recent AI-driven drug discovery collaborations and product expansions provide growth catalysts, though persistent negative cash flow and insider selling present concerns.
Outlook remains cautiously optimistic with 79% analyst buy ratings and a $91.63 consensus target. Investment opportunity centers on AI-enabled synthetic biology growth, while risks include sustained profitability challenges, cash burn, and competitive pressures in genomics. The stock trades at premium valuations (P/S 13.74) despite negative margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
